Selling And Administration Expenses 更改
Adma Biologics USD 24.59M 5.01M 2024-12
Alnylam Pharmaceuticals USD 295.34M 74.35M 2024-12
Dynavax Technologies USD 41.58M 1.48M 2024-12
Takeda JPY 270.59B 2.31B 2024-12



Adma Biologics 销售和管理费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Apr 2025.